Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04039139 · ClinicalTrials.gov registry record · NA

Mind Body Therapy for the Treatment of Chronic Pain

A NA study, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT04039139 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04039139, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

Chronic pain syndromes without identified organic etiology remain a challenge for physicians. Many syndromes, including back pain, are believed to have potential underlying psychological etiology; however, the exact link remains elusive. The goal of this study is to determine if mind body therapies can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of Mind Body Syndrome Therapy (MBST) in reducing disability from back pain and alleviating back pain. The investigators will secondarily investigate whether MBST can improve participant quality of life and reduce the need for pain-related hospitalization. The design of the this study consists of 3 arms with one being the intervention (MBST), one being usual care, and one being a second mind-body intervention (active control). This education program consists of a series of personal interviews and group and/or individualized lectures/sessions. Participants will also be provided reading material to study during the intervention period, and asked to continue their usual care while going through the MBST program.

Interventions

  • BEHAVIORAL Mind Body Intervention 1: Mind-Body-Syndrome-Therapy (MBST)
  • BEHAVIORAL Mind Body Intervention 2

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2019-07-30
Est. Completion 2020-04-20
Phase NA

What the Registry Record Tells You About NCT04039139

The ClinicalTrials.gov registry entry for NCT04039139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Mind Body Intervention 1: Mind-Body-Syndrome-Therapy (MBST) is the first listed.

NCT04039139 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04039139 about?

NCT04039139 is a clinical study titled "Mind Body Therapy for the Treatment of Chronic Pain". Chronic pain syndromes without identified organic etiology remain a challenge for physicians. Many syndromes, including back pain, are believed to have potential underlying psychological etiology; however, the exact link remains elusive. The goal of this study is to determine if mind body therapies ...

What is the current status of trial NCT04039139?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2019-07-30. Estimated completion is 2020-04-20.

What interventions are being tested in trial NCT04039139?

The interventions under investigation include: Mind Body Intervention 1: Mind-Body-Syndrome-Therapy (MBST) (BEHAVIORAL), Mind Body Intervention 2 (BEHAVIORAL).

Who is sponsoring clinical trial NCT04039139?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.